-The Hindu The Planning Commission’s perspective on universal health care causes concern Current deliberations in the Planning Commission about actualizing universal health care in the Twelfth Five Year Plan, have invited concerns. There has been a marked thrust on state-funded insurance as opposed to a genuine effort on the government’s part to rebuild public health systems, something that has been a globally time-tested system to ensure health for all. The ongoing discussions are...

-The Telegraph Jamshedpur: Work is underway on turning former Maoist hotbed West Singhbhum’s Manoharpur block into a hub of model villages sponsored by Union rural development ministry, a separate project that will operate simultaneously with the much-hyped Saranda Action Plan (SAP). The ministry headed by Jairam Ramesh has asked the state forest department to study all the 56 villages of the block and chalk out an integrated development project under the banner...

-DNA Mumbai has more undernourished children under the age of five than the whole of urban Maharashtra. Experts say malnutrition is prevalent amongthe slum dwellers, migrant labours and the city’s minority communities. A recent report on malnutrition, titled ‘India’s nutrition crisis: A challenge of putting nutrition back in our food’ by Narotam Sekhasaria Foundation, an NGO, reveals that more than half of the country’s upcoming generation— children under four years of age...

—AFP World farm production must rise 60 per cent by 2050 to meet the needs of a growing population but this has to happen in a “more sustainable way”, the U.N. food agency FAO and the OECD said on Wednesday. “It’s mostly going to be about productivity”, said Angel Gurria, head of the Organisation for Economic Cooperation and Development (OECD), at a press conference in Rome, explaining that farmland area would increase...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...